SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
10071982
Source:
http://linkedlifedata.com/resource/pubmed/id/10071982
Search
Subject
(
65
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0003138
,
umls-concept:C0031327
,
umls-concept:C0065461
,
umls-concept:C0671970
,
umls-concept:C1516213
pubmed:issue
4
pubmed:dateCreated
1999-3-23
pubmed:abstractText
In the present study the possible influence of the antacid Maalox on the pharmacokinetics of capecitabine (Xeloda) and its metabolites was investigated in cancer patients.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7806519
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Aluminum Hydroxide
,
http://linkedlifedata.com/resource/pubmed/chemical/Antacids
,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine
,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations
,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil
,
http://linkedlifedata.com/resource/pubmed/chemical/Magnesium Hydroxide
,
http://linkedlifedata.com/resource/pubmed/chemical/aluminum hydroxide, magnesium...
,
http://linkedlifedata.com/resource/pubmed/chemical/capecitabine
pubmed:status
MEDLINE
pubmed:issn
0344-5704
pubmed:author
pubmed-author:BankenLL
,
pubmed-author:CassidyJJ
,
pubmed-author:CliveSS
,
pubmed-author:GogginTT
,
pubmed-author:JodrellDD
,
pubmed-author:MulliganTT
,
pubmed-author:ReignerBB
,
pubmed-author:RoosBB
,
pubmed-author:SchulzRR
,
pubmed-author:UtohMM
,
pubmed-author:WeidekammEE
pubmed:issnType
Print
pubmed:volume
43
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
309-15
pubmed:dateRevised
2009-11-2
pubmed:meshHeading
pubmed-meshheading:10071982-Administration, Oral
,
pubmed-meshheading:10071982-Adult
,
pubmed-meshheading:10071982-Aged
,
pubmed-meshheading:10071982-Aluminum Hydroxide
,
pubmed-meshheading:10071982-Antacids
,
pubmed-meshheading:10071982-Antineoplastic Agents
,
pubmed-meshheading:10071982-Biotransformation
,
pubmed-meshheading:10071982-Cross-Over Studies
,
pubmed-meshheading:10071982-Deoxycytidine
,
pubmed-meshheading:10071982-Drug Combinations
,
pubmed-meshheading:10071982-Female
,
pubmed-meshheading:10071982-Fluorouracil
,
pubmed-meshheading:10071982-Half-Life
,
pubmed-meshheading:10071982-Humans
,
pubmed-meshheading:10071982-Magnesium Hydroxide
,
pubmed-meshheading:10071982-Male
,
pubmed-meshheading:10071982-Metabolic Clearance Rate
,
pubmed-meshheading:10071982-Middle Aged
,
pubmed-meshheading:10071982-Neoplasms
pubmed:year
1999
pubmed:articleTitle
Influence of the antacid Maalox on the pharmacokinetics of capecitabine in cancer patients.
pubmed:affiliation
Department of Pharma Development, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial